CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 186 filers reported holding CHEMOCENTRYX INC in Q2 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,424,000 | +360.8% | 56,800 | +570.4% | 0.00% | – |
| Q4 2021 | $309,000 | -91.3% | 8,473 | -95.9% | 0.00% | -100.0% |
| Q3 2021 | $3,568,000 | -61.9% | 208,664 | -70.1% | 0.00% | -62.5% |
| Q2 2021 | $9,353,000 | +42413.6% | 698,579 | +18588.6% | 0.01% | – |
| Q4 2017 | $22,000 | -93.1% | 3,738 | -97.1% | 0.00% | – |
| Q1 2016 | $321,000 | -69.3% | 128,957 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $1,045,000 | – | 128,957 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |